Emerging treatments are quickly changing the paradigm for metabolic dysfunction. MOTS-c, including other compounds , present potential avenues for addressing conditions like type two glucose intolerance and obesity . While studies are still in progress , initial findings imply remarkable benefits in blood sugar management and body loss , fueling si